Cytokinetics, Inc. (CYTK)
77.09
+0.25
(+0.33%)
USD |
NASDAQ |
Aug 24, 16:00
77.09
0.00 (0.00%)
After-Hours: 20:00
Cytokinetics Shareholders Equity (Quarterly) : -173.49M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -173.49M |
| March 31, 2026 | -826.57M |
| December 31, 2025 | -659.62M |
| September 30, 2025 | -521.12M |
| June 30, 2025 | -368.72M |
| March 31, 2025 | -266.41M |
| December 31, 2024 | -135.37M |
| September 30, 2024 | -13.91M |
| June 30, 2024 | 108.55M |
| March 31, 2024 | -396.16M |
| December 31, 2023 | -386.32M |
| September 30, 2023 | -438.80M |
| June 30, 2023 | -333.12M |
| March 31, 2023 | -229.02M |
| December 31, 2022 | -107.90M |
| September 30, 2022 | -15.98M |
| June 30, 2022 | 111.41M |
| March 31, 2022 | 116.26M |
| December 31, 2021 | 243.86M |
| September 30, 2021 | 249.02M |
| June 30, 2021 | 16.49M |
| March 31, 2021 | 67.85M |
| December 31, 2020 | 113.38M |
| September 30, 2020 | 149.60M |
| June 30, 2020 | -78.08M |
| Date | Value |
|---|---|
| March 31, 2020 | -45.71M |
| December 31, 2019 | -10.94M |
| September 30, 2019 | -19.87M |
| June 30, 2019 | -4.896M |
| March 31, 2019 | 3.372M |
| December 31, 2018 | 25.93M |
| September 30, 2018 | 52.07M |
| June 30, 2018 | 75.17M |
| March 31, 2018 | 99.60M |
| December 31, 2017 | 109.84M |
| September 30, 2017 | 147.04M |
| June 30, 2017 | 175.00M |
| March 31, 2017 | 95.38M |
| December 31, 2016 | 94.36M |
| September 30, 2016 | 84.72M |
| June 30, 2016 | 48.75M |
| March 31, 2016 | 57.91M |
| December 31, 2015 | 68.59M |
| September 30, 2015 | 67.30M |
| June 30, 2015 | 74.86M |
| March 31, 2015 | 84.15M |
| December 31, 2014 | 92.06M |
| September 30, 2014 | 73.63M |
| June 30, 2014 | 78.70M |
| March 31, 2014 | 86.18M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 1.359B |
| Ionis Pharmaceuticals, Inc. | 439.74M |
| Bristol Myers Squibb Co. | 22.32B |
| Gilead Sciences, Inc. | 11.83B |
| Rigel Pharmaceuticals, Inc. | 425.42M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.925B |
| Total Liabilities (Quarterly) | 2.098B |
| Debt to Equity Ratio | -7.324 |
| Current Ratio | 6.661 |
| Net Debt Paydown Yield | -0.81% |